This observation generates the interesting hypothesis that sildenafil could be tested in vivo as an CXCL10 inhibitor during muscle involvement, and not limited to treat digital ulcers or PAH secondary to the disease. The gene discussed is CXCL10; the disease is pulmonary arterial hypertension.